Open Access Highly Accessed Research article

Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy

Cheng Liao*, Jonathan Hsu, Yong Kim, Dong-Qing Hu, Daigen Xu, Jun Zhang, Achal Pashine, John Menke, Toni Whittard, Natasha Romero, Theresa Truitt, Michelle Slade, Christine Lukacs, Johannes Hermann, Mingyan Zhou, Matthew Lucas, Satwant Narula, Julie DeMartino and Seng-Lai Tan

Arthritis Research & Therapy 2013, 15:R146  doi:10.1186/ar4329

Article Metrics

4650
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 244 accesses
  • Last 365 days: 4650 accesses
  • All time: 4650 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information